Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.58 |
| ▸ | NPC1 | O15118 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17505996 | 1.00 | RAB9A (0.58) | RAB9ANPC1SMN1; SMN2EPHX1EPHX2 | |
| SCHEMBL19181031 | 0.90 | RAB9A (0.53) | RAB9ANPC1SMN1; SMN2EPHX1EPHX2 | |
| SCHEMBL17524121 | 0.90 | RAB9A (0.53) | RAB9ANPC1SMN1; SMN2EPHX1EPHX2 | |
| SCHEMBL17524125 | 0.87 | RAB9A (0.55) | RAB9ANPC1SMN1; SMN2KMT2AHTT | |
| SCHEMBL17523662 | 0.86 | EPHX1 (0.51) | RAB9ANPC1SMN1; SMN2EPHX1EPHX2 | |
| SCHEMBL17523652 | 0.85 | ESR1 (0.58) | RAB9ANPC1TP53KMT2AMAPT | |
| SCHEMBL19201099 | 0.83 | RAB9A (0.51) | RAB9ANPC1SMN1; SMN2EPHX1EPHX2 | |
| SCHEMBL19200748 | 0.82 | SMN1; SMN2 (0.50) | RAB9ANPC1SMN1; SMN2EPHX1TP53 | |
| SCHEMBL17506011 | 0.80 | CASR (0.57) | RAB9ANPC1EPHX1TSHRMAPT | |
| SCHEMBL17506010 | 0.80 | CASR (0.57) | RAB9ANPC1EPHX1TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170217914-A1 | Novel Triarylethylene Compounds and Methods Using Same | THE PENN STATE RESEARCH FOUNDATION | 2017-08-03 | — | — | US | disclosed |
| WO-2016022325-A1 | NOVEL TRIARYLETHYLENE COMPOUNDS AND METHODS USING SAME | THE PENN STATE RESEARCH FOUNDATION (US) | 2016-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170217914-A1 | Novel Triarylethylene Compounds and Methods Using Same | CYP46A1, GSTA2, GSTA1 | RAB9A 2537/4885NPC1 23/4885SMN1; SMN2 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.